Rigel Pharmaceuticals Inc
NASDAQ:RIGL

Watchlist Manager
Rigel Pharmaceuticals Inc Logo
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Watchlist
Price: 19.48 USD 3.84% Market Closed
Market Cap: 348.1m USD

Relative Value

The Relative Value of one RIGL stock under the Base Case scenario is hidden USD. Compared to the current market price of 19.48 USD, Rigel Pharmaceuticals Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RIGL Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
78
Median 3Y
10.5
Median 5Y
22.5
Industry
7.1
Forward
1.7
vs History
11
vs Industry
8
Median 3Y
-15.8
Median 5Y
-51.3
Industry
22.9
Forward
16.5
vs History
30
vs Industry
13
Median 3Y
-28.8
Median 5Y
-31.8
Industry
19.4
vs History
25
vs Industry
11
Median 3Y
-24.2
Median 5Y
-38.2
Industry
22.6
vs History
47
vs Industry
0
Median 3Y
-19.7
Median 5Y
18
Industry
2.7
vs History
90
vs Industry
69
Median 3Y
10.5
Median 5Y
22.3
Industry
7.4
Forward
1.5
vs History
88
vs Industry
70
Median 3Y
10.8
Median 5Y
22.7
Industry
9.2
vs History
11
vs Industry
10
Median 3Y
-25.2
Median 5Y
-56.1
Industry
4.5
Forward
11
vs History
11
vs Industry
9
Median 3Y
-20.7
Median 5Y
-54.6
Industry
4.5
Forward
10.8
vs History
30
vs Industry
13
Median 3Y
-28.2
Median 5Y
-30.9
Industry
5
vs History
20
vs Industry
10
Median 3Y
-27.3
Median 5Y
-34
Industry
3.7
vs History
88
vs Industry
35
Median 3Y
30.8
Median 5Y
47.2
Industry
4.9

Multiples Across Competitors

RIGL Competitors Multiples
Rigel Pharmaceuticals Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
348m USD 1.7 9.4 6.8 7.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 936 878.5 -161 297 -195 865.9 -193 630.9
US
Abbvie Inc
NYSE:ABBV
322B USD 5.6 77.5 14.8 21.9
US
Amgen Inc
NASDAQ:AMGN
149B USD 4.4 25.1 13.7 22.6
US
Gilead Sciences Inc
NASDAQ:GILD
137.8B USD 4.8 23.1 10 13.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.4B USD 10.2 -114.7 24.3 25.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 075.9 -529.7 -576.8 -561.4
AU
CSL Ltd
ASX:CSL
113.5B AUD 4.9 27 16.7 20.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
56.4B USD 4 12.5 11.1 12.5
US
Seagen Inc
F:SGT
39.3B EUR 20 -61.3 -66.1 -59.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.1B USD 17.9 -156 -699.8 -350.7
P/E Multiple
Earnings Growth PEG
US
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Average P/E: 29.1
9.4
55%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 297 N/A N/A
US
Abbvie Inc
NYSE:ABBV
77.5
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
25.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.1
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -114.7 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.7 N/A N/A
AU
CSL Ltd
ASX:CSL
27
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.5
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -156 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Average EV/EBITDA: 13.9
6.8
62%
0.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 865.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
14.8
13%
1.1
US
Amgen Inc
NASDAQ:AMGN
13.7
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.3
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -576.8 N/A N/A
AU
CSL Ltd
ASX:CSL
16.7
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.1
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -699.8 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Average EV/EBIT: 17.8
7.2
43%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 630.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
21.9
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
22.6
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.9
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.5
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.4 N/A N/A
AU
CSL Ltd
ASX:CSL
20.9
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.5
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -350.7 N/A N/A